1,303
Views
17
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Methylprednisolone acetate–Eudragit® RS100 electrospuns: Preparation and physicochemical characterization

, , , , , & show all
Pages 497-503 | Received 25 Aug 2014, Accepted 10 Sep 2014, Published online: 07 Oct 2014

References

  • Adibkia K, Javadzadeh Y, Dastmalchi S, Mohammadi G, Niri FK, Alaei-Beirami M. 2011. Naproxen-eudragit RS100 nanoparticles: preparation and physicochemical characterization. Colloids Surf B Biointerfaces. 83:155–159.
  • Adibkia K, Omidi Y, Siahi MR, Javadzadeh AR, Barzegar-Jalali M, Barar J, et al. 2007a. Inhibition of endotoxin-induced uveitis by methylprednisolone acetate nanosuspension in rabbits. J Ocul Pharm Ther. 23:421–432.
  • Adibkia K, Shadbad MRS, Nokhodchi A, Javadzedeh A, Barzegar-Jalali M, Barar J, et al. 2007b. Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis. J Drug Target. 15:407–416.
  • Adibkia K, Siahi Shadbad MR, Nokhodchi A, Javadzedeh A, Barzegar-Jalali M, Barar J, et al. 2007c. Piroxicam nanoparticles for ocular delivery: physicochemical characterization and implementation in endotoxin-induced uveitis. J Drug Target. 15:407–416.
  • Akhgari A, Heshmati Z, Sharif Makhmalzadeh B. 2013. Indomethacin electrospun nanofibers for colonic drug delivery: preparation and characterization. Adv Pharm Bull. 3:85–90.
  • Barzegar-Jalali M. 2008. Kinetic analysis of drug release from nanoparticles. J Pharm Pharm Sci. 11:167–177.
  • Barzegar-Jalali M, Adibkia K, Valizadeh H, Shadbad MR, Nokhodchi A, Omidi Y, et al. 2008. Kinetic analysis of drug release from nanoparticles. J Pharm Pharm Sci. 11:167–177.
  • Bhardwaj N, Kundu S. 2010. Electrospinning: A fascinating fiber fabrication technique. Biotechnol Adv. 28:325–347.
  • Canbolat MF, Celebioglu A, Uyar T. 2013. Drug delivery system based on cyclodextrin-naproxen inclusion complex incorporated in electrospun polycaprolactone nanofibers. Colloids Surf B Biointerfaces. 115C:15–21.
  • Chaturvedi TP, Srivastava R, Srivastava AK, Gupta V, Verma PK. 2013. Doxycycline poly e-caprolactone nanofibers in patients with chronic periodontitis - a clinical evaluation. J Clin Diagn Res. 7:2339–2342.
  • Chinnappan A, Kim H. 2012. Nanocatalyst: Electrospun nanofibers of PVDF – Dicationic tetrachloronickelate (II) anion and their effect on hydrogen generation from the hydrolysis of sodium borohydride. Int J Hydrogen Energy. 37:18851–18859.
  • Chowdhury M, Stylios G. 2010. Effect of experimental parameters on the morphology of electrospun nylon 6 fibres. Int J Basic Appl Sci. 10:70–78.
  • Costa P, Sousa Lobo JM. 2001. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 13:123–133.
  • Damgé C, Michel C, Aprahamian M, Couvreur P. 1988. New approach for oral administration of insulin with polyalkylcyanoacrylate nanocapsules as drug carrier. Diabetes. 37:246–251.
  • Douglas S, Davis S, Illum L. 1986. Nanoparticles in drug delivery. Crit Rev Ther Drug Carrier Syst. 3:233–261.
  • Doustgani A, Vasheghani-Farahani E, Soleimani M, Hashemi- Najafabadi S. 2011. Preparation and characterization of aligned and random nanofibrous nanocomposite scaffolds of poly (vinyl alcohol), poly (e-Caprolactone) and nanohydroxyapatite. Int J Nanosci Nanotechnol. 7:127–132.
  • Eerikäinen H, Watanabe W, Kauppinen E, Petri Ahonen P. 2003. Aerosol flow reactor method for synthesis of drug nanoparticles. Eur J Pharm Biopharm. 55:357–360.
  • Hwang J, Rodgers K, Oliver JC, Schluep T. 2008. α-Methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy . Int J Nanomed. 3:359.
  • Illangakoon UE, Nazir T, Williams GR, Chatterton NP. 2014. Mebeverine-loaded electrospun nanofibers: physicochemical characterization and dissolution studies. J Pharm Sci. 103:283–292.
  • Javadzadeh Y, Ahadi F, Davaran S, Mohammadi G, Sabzevari A, Adibkia K. 2010. Preparation and physicochemical characterization of naproxen–PLGA nanoparticles. Colloids Surf B. 81:498–502.
  • Kim K, Luu YK, Chang C, Fang D, Hsiao BS, Chu B, Hadjiargyrou M. 2004. Incorporation and controlled release of a hydrophilic antibiotic using poly (lactide-co-glycolide)-based electrospun nanofibrous scaffolds. J Control Release. 98:47–56.
  • Kocbek P, Baumgartner S, Kristl J. 2006. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs. Int J Pharm. 312:179–186.
  • Krishna Sailaja A, Amareshwar P, Chakravarty P. 2011. Different techniques used for the preparation of nanoparticles using natural polymers and their application. Int J Pharm Pharm Sci. 3.
  • Liu H, Webster TJ. 2007. Nanomedicine for implants: A review of studies and necessary experimental tools. Biomaterials. 28:354–369.
  • Loveymi BD, Jelvehgari M, Zakeri-Milani P, Valizadeh H. 2012. Design of vancomycin RS-100 nanoparticles in order to increase the intestinal permeability. Adv Pharm Bull. 2:43.
  • Luu YK, Kim K, Hsiao BS, Chu B, Hadjiargyrou M. 2003. Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG block copolymers. J Control Release. 89:341–353.
  • Martins A, Reis RL, Neves NM. 2008. Electrospinning: processing technique for tissue engineering scaffolding. Int Mater Rev. 53:257–274.
  • Midhun B, Shalumon K, Manzoor K, Jayakumar R, Nair S, Deepthy M. 2011. Preparation of budesonide-loaded polycaprolactone nanobeads by electrospraying for controlled drug release. J Biomater Sci Polym Ed. 22:2431–2444.
  • Mohammadi G, Valizadeh H, Barzegar-Jalali M, Lotfipour F, Adibkia K, Milani M, et al. 2010. Development of azithromycin– PLGA nanoparticles: Physicochemical characterization and antibacterial effect against Salmonella typhi. Colloids Surf B Biointerfaces. 80:34–39.
  • Oh B, Lee CH. 2013. Advanced cardiovascular stent coated with nanofiber. Mol Pharm. 10:4432–4442.
  • Pham Q, Sharma U, Mikos A. 2006. Electrospinning of polymeric nanofibers for tissue engineering applications: a review. Tissue Eng. 12:1197–1211.
  • Pignatello R, Amico D, Chiechio S, Spadaro C, Puglisi G, Giunchedi P. 2001. Preparation and analgesic activity of Eudragit RS100® microparticles containing Diflunisal. Drug Deliv. 8:35–45.
  • Pignatello R, Bucolo C, Ferrara P, Maltese A, Puleo A, Puglisi G. 2002. Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci. 16:53–61.
  • Pignatello R, Consoli P, Puglisi G. 2000. In vitro release kinetics of Tolmetin from tabletted Eudragit microparticles. J Microencapsul. 17:373–383.
  • Pires LR, Guarino V, Oliveira MJ, Ribeiro CC, Barbosa MA, Ambrosio L, Pego AP. 2013. Ibuprofen-loaded poly(trimethylene carbonate-co-epsilon-caprolactone) electrospun fibres for nerve regeneration. J Tissue Eng Regen Med. (Epub ahead of print).
  • Prisant LM, Bottini B, DiPiro JT, Carr AA. 1992. Novel drug-delivery systems for hypertension. Am J Med. 93:45S–55S.
  • Rajesh KP, Natarajan TS. 2009. Electrospun polymer nanofibrous membrane for filtration. J Nanosci Nanotechnol. 9:5402–5405.
  • Reddy KR. 2000. Controlled-release, pegylation, liposomal formulations: new mechanisms in the delivery of injectable drugs. Ann Pharmacother. 34:915–923.
  • Sargeant TD, Guler MO, Oppenheimer SM, Mata A, Satcher RL, Dunand DC, Stupp SI. 2008. Hybrid bone implants: self-assembly of peptide amphiphile nanofibers within porous titanium. Biomaterials. 29:161–171.
  • Shi Y, Wei Z, Zhao H, Liu T, Dong A, Zhang J. 2013. Electrospinning of ibuprofen-loaded composite nanofibers for improving the performances of transdermal patches. J Nanosci Nanotechnol. 13:3855–3863.
  • Snopczynski T, Goralczyk K, Czaja K, Strucinski P, Hernik A, Korcz W, Ludwicki JK. 2009. [Nanotechnology–possibilities and hazards]. Rocz Panstw Zakl Hig. 60:101–111.
  • Sode K, Tanaka M, Suzuki Y, Kawakami H. 2013. Nickel nanoparticle chains inside carbonized polymer nanofibers: preparation by electrospinning and ion-beam irradiation. Nanoscale. 5: 8235–8241.
  • Subbiah T, Bhat GS, Tock RW, Parameswaran S, Ramkumar SS. 2005. Electrospinning of nanofibers. J Appl Polym Sci. 96:557–569.
  • Tantishaiyakul V, Kaewnopparat N, Ingkatawornwong S. 1999. Properties of solid dispersions of piroxicam in polyvinylpyrrolidone. Int J Pharm. 181:143–151.
  • Thavasi V, Singh G, Ramakrishna S. 2008. Electrospun nanofibers in energy and environmental applications. Energy Environ Sci. 1:205–221.
  • Vrbata P, Berka P, Stranska D, Dolezal P, Musilova M, Cizinska L. 2013. Electrospun drug loaded membranes for sublingual administration of sumatriptan and naproxen. Int J Pharm. 457:168–176.
  • Wagner JG. 1969. Interpretation of percent dissolved‐time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci. 58:1253–1257.
  • Wang X, Drew C, Lee SH, Senecal KJ, Kumar J, Samuelson LA. 2002. Electrospun nanofibrous membranes for highly sensitive optical sensors. Nano Lett. 2:1273–1275.
  • Yu D-G, Zhu L-M, White K, Branford-White C. 2009. Electrospun nanofiber-based drug delivery systems. Health. 1:67–75.
  • Yu JH, Fridrikh SV, Rutledge GC. 2006. The role of elasticity in the formation of electrospun fibers. Polymer. 47:4789–4797.
  • Zabaleta V, Ponchel G, Salman H, Agüeros M, Vauthier C, Irache JM. 2012. Oral administration of paclitaxel with pegylated poly (anhydride) nanoparticles: permeability and pharmacokinetic study. Eur J Pharm Biopharm. 81:514–523.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.